This site uses cookies to improve your experience. To help us insure we adhere to various privacy regulations, please select your country/region of residence. If you do not select a country, we will assume you are from the United States. Select your Cookie Settings or view our Privacy Policy and Terms of Use.
Cookies and similar technologies are used on this website for proper function of the website, for tracking performance analytics and for marketing purposes. We and some of our third-party providers may use cookie data for various purposes. Please review the cookie settings below and choose your preference.
Used for the proper function of the website
Used for monitoring website traffic and interactions
Cookies and similar technologies are used on this website for proper function of the website, for tracking performance analytics and for marketing purposes. We and some of our third-party providers may use cookie data for various purposes. Please review the cookie settings below and choose your preference.
Cardiovascular Interventions Circulation Outcomes 
Circulation: Cardiovascular Interventions
MARCH 9, 2025
Circulation: Cardiovascular Interventions, Ahead of Print. However, the impact of nickel hypersensitivity on post-procedural outcomes remains poorly understood. These findings highlight the need for further research to optimize device selection and improve outcomes in nickel-hypersensitive patients.
70 
Circulation: Cardiovascular Interventions
MARCH 4, 2024
Circulation: Cardiovascular Interventions, Ahead of Print. High-volume MVr centers and high-volume TEER centers have better outcomes than low-volume centers, respectively. High-volume MVr centers and high-volume TEER centers have better outcomes than low-volume centers, respectively.
Circulation: Cardiovascular Interventions
JANUARY 22, 2025
Circulation: Cardiovascular Interventions, Ahead of Print. Some patients with aortic stenosis may require multiple valve interventions in their lifetime, and choosing transcatheter aortic valve replacement (TAVR) as the initial intervention may be appealing to many.
73 
Circulation: Cardiovascular Interventions
APRIL 2, 2025
Circulation: Cardiovascular Interventions, Ahead of Print.
Circulation: Cardiovascular Interventions
MAY 24, 2024
Circulation: Cardiovascular Interventions, Ahead of Print.
Circulation: Cardiovascular Interventions
JANUARY 24, 2024
Circulation: Cardiovascular Interventions, Ahead of Print. Principal safety outcomes were independently adjudicated International Society on Thrombosis and Haemostasis major bleeding at 72 hours post-treatment and mortality within 12 months of treatment.
75 
Circulation: Cardiovascular Interventions
JANUARY 20, 2025
Circulation: Cardiovascular Interventions, Volume 18, Issue 1 , Page e014681, January 1, 2025.
Circulation: Cardiovascular Interventions
JANUARY 20, 2025
Circulation: Cardiovascular Interventions, Volume 18, Issue 1 , Page e014991, January 1, 2025.
40 
Circulation: Cardiovascular Interventions
JULY 29, 2024
Circulation: Cardiovascular Interventions, Ahead of Print.
40 
American College of Cardiology
JUNE 24, 2024
Greater adverse events were associated with both low and high postprocedural aortic valve mean gradient extremes following transcatheter aortic valve implantation (TAVI) for degenerated surgical aortic valve replacement (SAVR) bioprostheses, indicating a complex and nonlinear relationship between gradients and clinical outcomes, according to a recent (..)
49 
Circulation: Cardiovascular Interventions
MARCH 17, 2025
Circulation: Cardiovascular Interventions, Volume 18, Issue 3 , Page e014819, March 1, 2025. However, the risk of 1-year mortality was not higher in nondegenerative etiologies compared with DMR.
Circulation: Cardiovascular Interventions
JANUARY 20, 2025
Circulation: Cardiovascular Interventions, Volume 18, Issue 1 , Page e014499, January 1, 2025. BACKGROUND:The aim of this study was to examine the impact of early versus delayed catheter-based therapies (CBTs) on clinical outcomes in patients with acute intermediate-risk pulmonary embolism (PE).METHODS:This days;P=0.046).
40 
Circulation: Cardiovascular Interventions
DECEMBER 28, 2023
Circulation: Cardiovascular Interventions, Ahead of Print. We compared outcomes between the conventional implantation method using the 3-cusps view (3 cusps without ICE group), the recent method using cusp-overlap view (cusp overlap without ICE group), and our novel method using ICE (cusp overlap with ICE group).RESULTS:Of
76 
Circulation: Cardiovascular Interventions
OCTOBER 22, 2023
Circulation: Cardiovascular Interventions, Ahead of Print. Background:Atherosclerotic cardiovascular disease (ASCVD) is highly prevalent in patients with severe aortic stenosis undergoing transcatheter aortic valve replacement (TAVR). Primary outcome was all-cause mortality. Primary outcome was all-cause mortality.
40 
Circulation: Cardiovascular Interventions
FEBRUARY 27, 2024
Circulation: Cardiovascular Interventions, Ahead of Print. Propensity score matching was utilized to compare adjusted outcomes between patients receiving advanced therapies versus anticoagulation alone.Results:A total of 345 patients were included in the study. The primary end point was 90-day all-cause mortality.
40 
Circulation: Cardiovascular Interventions
JANUARY 18, 2024
Circulation: Cardiovascular Interventions, Ahead of Print. BACKGROUND:Limited data exist regarding the impact of mitral annular calcification (MAC) on outcomes of transcatheter edge-to-edge repair for mitral regurgitation (MR).METHODS:We with functional MR) who underwent an isolated, first-time intervention.
Circulation: Cardiovascular Interventions
OCTOBER 17, 2023
Circulation: Cardiovascular Interventions, Ahead of Print. BACKGROUND:Data concerning the outcomes of transcatheter aortic valve replacement in type 0 bicuspid aortic stenosis (AS) are scarce.
40 
Circulation: Cardiovascular Interventions
DECEMBER 28, 2023
Circulation: Cardiovascular Interventions, Ahead of Print. BACKGROUND:Lower-limb amputation rates in patients with chronic limb-threatening ischemia vary across the United States, with marked disparities in amputation rates by gender, race, and income status.
Circulation: Cardiovascular Interventions
NOVEMBER 6, 2023
Circulation: Cardiovascular Interventions, Ahead of Print. Data on transcatheter palliation are limited.Methods:We present our experience with pulmonary flow restrictors (PFRs) for palliation of neonates with congenital heart disease, including procedural feasibility, technical details, and outcomes. kilograms [IQR, 2.1–3.3])
Circulation: Cardiovascular Interventions
JANUARY 24, 2025
Circulation: Cardiovascular Interventions, Ahead of Print. BACKGROUND:Intravascular imaging (IVI) is widely recognized to improve outcomes after percutaneous coronary intervention (PCI). in 2010 to 43.1% in 2022 in 136 071 PCIs included in the study.
45 
Circulation: Cardiovascular Interventions
MARCH 20, 2025
Circulation: Cardiovascular Interventions, Ahead of Print. Procedural outcomes, 30-day survival, and echo findings are reported.RESULTS:Fourteen patients (71% women, mean age 77.9 BACKGROUND:Many patients with atrial functional mitral regurgitation are not suitable candidates for surgery or transcatheter repair.
Circulation: Cardiovascular Interventions
FEBRUARY 27, 2024
Circulation: Cardiovascular Interventions, Ahead of Print. BACKGROUND:The American College of Cardiology Reduce the Risk: PCI Bleed Campaign was a hospital-based quality improvement campaign designed to reduce post-percutaneous coronary intervention (PCI) bleeding events.
Circulation: Cardiovascular Interventions
NOVEMBER 20, 2023
Circulation: Cardiovascular Interventions, Volume 16, Issue 11 , Page e012966, November 1, 2023. Conversely, TAVR-explant can be offered to most patients who are surgical candidates, but the reported outcomes have shown high mortality and morbidity.
40 
Circulation: Cardiovascular Interventions
APRIL 7, 2025
Circulation: Cardiovascular Interventions, Ahead of Print. Cost and utilization outcomes by stage of cardiac damage were estimated using covariate-adjusted generalized linear models.RESULTS:A total of 24 644 patients with AVR were included in our analysis. in stage 0, 17.1% in stage 1, 37.3% in stage 2, 36.2%
40 Circulation: Cardiovascular Interventions
JANUARY 23, 2024
Circulation: Cardiovascular Interventions, Ahead of Print. kg at all Congenital Cardiac Catheterization Project on Outcomes participating centers. kg at all Congenital Cardiac Catheterization Project on Outcomes participating centers.
Circulation: Cardiovascular Interventions
MARCH 24, 2025
Circulation: Cardiovascular Interventions, Ahead of Print. The primary outcome was RA graft failure (modified Fitzgibbon grade B, S, or O) at 1 and 24 weeks, assessed by coronary computed tomography angiography.RESULTS:Among 150 randomized participants, 149 (mean age, 56.8
Circulation: Cardiovascular Interventions
DECEMBER 4, 2024
Circulation: Cardiovascular Interventions, Ahead of Print. Whereas the field of transradial arterial access for peripheral vascular interventions is in development, it is clear that this approach, at least with available equipment, will not be suitable for all patients, and careful case selection is paramount.
Circulation: Cardiovascular Interventions
JANUARY 24, 2025
Circulation: Cardiovascular Interventions, Ahead of Print. BACKGROUND:Transcatheter heart valve (THV) underexpansion after transcatheter aortic valve replacement may be associated with worse outcomes.
40 
Circulation: Cardiovascular Interventions
NOVEMBER 20, 2023
Circulation: Cardiovascular Interventions, Volume 16, Issue 11 , Page e013296, November 1, 2023. Procedural and outcome data were obtained from 10 patients who had undergone Redo TAVI for Lotus bioprosthetic valve failure in 5 centers. Bench-top analysis of Redo TAVI was performed using different contemporary THVs.
40 Circulation: Cardiovascular Interventions
NOVEMBER 9, 2023
Circulation: Cardiovascular Interventions, Ahead of Print. Background:There are limited data about changes in cardiac function (cardiac reverse remodeling) and heart failure indices after transcatheter tricuspid valve-in-valve replacement (TT-VIVR).
Circulation: Cardiovascular Interventions
JANUARY 15, 2024
Circulation: Cardiovascular Interventions, Volume 17, Issue 1 , Page e013481, January 1, 2024. The primary outcome was the change in the values of the index of microcirculatory resistance. Secondary end points included changes in coronary flow reserve and the resistive resistance ratio values.
40 
DAIC
OCTOBER 16, 2024
16, 2024 — Sahajanand Medical Technologies (SMT) recently announced the publication of the COMPARE 60/80 HBR trial results in Circulation: Cardiovascular Interventions , a journal of The American Heart Association. tim.hodson Wed, 10/16/2024 - 09:00 Oct. Led by Dr. Pieter C.
52 
DAIC
DECEMBER 26, 2023
I am eager to engage with our community worldwide to build on its past successes and find new ways to contribute to achieving ever better patient outcomes and more equitable, effective, efficient and evidence-based clinical care.” Krumholz is the Harold H. In addition, he co-founded medRxiv , a leading preprint server for clinical medicine.
52 
Dr. Smith's ECG Blog
AUGUST 3, 2017
Circulation. These patients had worse outcomes than patients with ST depression without occlusion; half of these were circumflex. O'Gara et al. There are several studies that indirectly reveal the proportion of STEMIs that are isolated to the posterior wall, and they range from 3% to 11%. (1, J Am Coll Card 1999;34(3):748-53.
52 
Circulation: Cardiovascular Interventions
MARCH 17, 2025
Circulation: Cardiovascular Interventions, Volume 18, Issue 3 , Page e014899, March 1, 2025. BACKGROUND:Ineligibility for surgical revascularization is increasingly prevalent and associated with increased mortality after percutaneous coronary intervention (PCI).
Circulation: Cardiovascular Interventions
DECEMBER 27, 2024
Circulation: Cardiovascular Interventions, Ahead of Print. Inverse probability weighting was used to assess the impact of IVUS on a composite outcome of repeat aortic intervention or death.
40 
Circulation: Cardiovascular Interventions
JUNE 10, 2024
Circulation: Cardiovascular Interventions, Ahead of Print. We reported the feasibility and short-term outcomes of percutaneous transcatheter therapy with cerebral embolic protection. BACKGROUND:Surgery or fibrinolysis is the currently available evidence-based treatment for obstructive mechanical valve thrombus.
40 
Circulation: Cardiovascular Interventions
NOVEMBER 28, 2023
Circulation: Cardiovascular Interventions, Ahead of Print. BACKGROUND:There are limited data regarding the safety of deferral of percutaneous coronary intervention based on intravascular ultrasound (IVUS) findings. versus 4.1%; hazard ratio, 0.91 [95% CI, 0.47–1.75];P=0.77). 1.75];P=0.77). 2.19];P=0.81) and FFR (4.1%
40 
Circulation: Cardiovascular Interventions
JANUARY 20, 2025
Circulation: Cardiovascular Interventions, Volume 18, Issue 1 , Page e014592, January 1, 2025. We additionally compared end points across treatment arms using trial-adjudicated outcomes versus claims-based outcomes.RESULTS:Trial-adjudicated deaths were perfectly identified by claims.
40 Circulation: Cardiovascular Interventions
MARCH 26, 2025
Circulation: Cardiovascular Interventions, Ahead of Print. The primary outcome was a composite of death from any cause, stroke/transient ischemic attack, and procedure-related or valve-related hospitalization at 30 days and at 1 year. versus 4.3%; hazard ratio, 2.93 [95% CI, 1.455.94]). andP=0.001, respectively).
40 
Circulation: Cardiovascular Interventions
MARCH 30, 2025
Circulation: Cardiovascular Interventions, Ahead of Print. Background:Optical coherence tomography (OCT) provides high-resolution intracoronary imaging. Updated guidelines should strengthen recommendations supporting the use of OCT guidance for complex PCI.
40 Circulation: Cardiovascular Interventions
JANUARY 31, 2024
Circulation: Cardiovascular Interventions, Ahead of Print. BACKGROUND:In patients with ST-segment–elevation myocardial infarction complicated by cardiogenic shock, primary percutaneous coronary intervention (pPCI) is the preferred revascularization option. The incidence of the primary safety outcome was 10.1%
Circulation: Cardiovascular Interventions
JANUARY 18, 2024
Circulation: Cardiovascular Interventions, Ahead of Print. Background:Frailty associates with worse outcomes after transcatheter aortic valve replacement (TAVR). Lower visceral fat was also associated with increased risk pointing to an obesity paradox also observed in other patient populations.
40 
Circulation: Cardiovascular Interventions
FEBRUARY 27, 2024
Circulation: Cardiovascular Interventions, Ahead of Print. INTRODUCTION:Percutaneous coronary intervention for complex coronary disease is associated with a high risk of cardiogenic shock. Cardiogenic shock and acute ST-segment–elevation myocardial infarction are exclusions.
Expert insights. Personalized for you.
We have resent the email to
Are you sure you want to cancel your subscriptions?
Let's personalize your content